Drugs / SAGE-904
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05049343 | Sep → Nov 2021 | — | Supernus Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAGE-904 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05049343 ↗ |
| Route | Oral | “SAGE-904 oral solution.” NCT05049343 ↗ |